尚荣医疗收盘上涨4.52%，滚动市盈率192.44倍，总市值43.04亿元

Core Viewpoint - The company, Shangrong Medical, has seen its stock price rise to 5.09 yuan, marking a 4.52% increase, while its rolling PE ratio has reached a new low of 192.44 times, significantly higher than the industry average of 58.46 times [1][2] Company Overview - Shangrong Medical specializes in the production and sales of medical products, medical services, and health industry operations, being one of the first companies in China to introduce clean technology into hospital operating rooms [1] - The company has received numerous accolades, including national key new product honors and a second-class award for scientific and technological progress from the Shenzhen municipal government [1] - Shangrong Medical is recognized as a national high-tech enterprise and has accumulated over 180 patents, which serve as a driving force for its continuous development [1] Financial Performance - In the first quarter of 2025, the company reported an operating income of 280 million yuan, a year-on-year increase of 1.30%, and a net profit of 13.96 million yuan, reflecting a year-on-year growth of 0.58% [2] - The company's gross profit margin stands at 15.27% [2] Shareholder Information - As of March 31, 2025, the number of shareholders in Shangrong Medical is 58,323, a decrease of 621 from the previous count, with an average holding value of 352,800 yuan per shareholder and an average holding of 27,600 shares [1]